Truist Financial Corp Sells 2,231 Shares of Humana Inc. $HUM

Truist Financial Corp lowered its stake in shares of Humana Inc. (NYSE:HUM) by 32.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,611 shares of the insurance provider’s stock after selling 2,231 shares during the quarter. Truist Financial Corp’s holdings in Humana were worth $1,127,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HUM. Cary Street Partners Investment Advisory LLC boosted its position in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares during the period. Garde Capital Inc. acquired a new position in shares of Humana during the first quarter worth approximately $36,000. Zions Bancorporation National Association UT acquired a new position in shares of Humana during the first quarter worth approximately $37,000. Ransom Advisory Ltd acquired a new position in shares of Humana during the first quarter worth approximately $66,000. Finally, Rakuten Securities Inc. lifted its holdings in shares of Humana by 50.0% during the first quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider’s stock worth $79,000 after buying an additional 100 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of research analyst reports. Robert W. Baird cut their price target on Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Truist Financial cut their price target on Humana from $280.00 to $260.00 and set a “hold” rating for the company in a report on Wednesday, July 16th. Wall Street Zen lowered Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Wolfe Research upped their price target on Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $298.83.

Humana Trading Down 3.6%

HUM stock opened at $280.24 on Monday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The firm has a market cap of $33.71 billion, a P/E ratio of 21.51, a P/E/G ratio of 1.64 and a beta of 0.42. The business’s 50 day moving average is $279.45 and its 200-day moving average is $258.04. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. During the same period in the prior year, the firm earned $6.96 EPS. Humana’s quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.